[vc_row][vc_column][vc_column_text]NHK is one of the largest broadcasting corporations in Japan, providing international services on numerous TV programs, radio, and the Internet. Currently documenting on the advancements of neuromodulation technologies, in February 2019, the NHK production
Click to register for the event Thursday, 28 February 2019 5:30-8:00 pm PST LifeScan Canada 210-4321 Still Creek Drive Burnaby, BC V5C 6S7 Drugs, devices, natural health products…cannabis? Canada’s new Cannabis Act introduces another arm of health
For more information, please visit: www.amazon.co.uk and www.amazon.ca.
MD Anderson Cancer Center is a globally recognized cancer research organization. With emphasis on cancer patient care, research, education, and prevention, the center is devoted to the goal of eliminating cancer worldwide. To support
VANCOUVER, British Columbia, Oct. 31, 2018 /PRNewswire/ — WAT Medical would go back 2018 Medica Show to exhibit innovative wearable technologies EmeTerm, an anti-vomiting wrist band, and HeadaTerm, an anti-migraine head patch. WAT Medical is
VANCOUVER, British Columbia, Oct. 5, 2018 /PRNewswire/ –Terveystekniikka Oy, a strategic partner of WAT Medical Enterprise Ltd. (WAT Med), will participate in “I love me 2018”, the biggest health expo of Finland held from October 19-21, 2018. HeadaTerm and EmeTerm, signature medical devices developed by
WAT Medical’s innovative technology to treat all primary headaches, HeadaTerm, received its FDA clearance in September, 2018. This product, already approved by CE, HC, and now FDA, has been distributed in over 20 countries around
On August 20, 2018, Benny, CEO of B. Medical, visited WAT Med. Both parties held an in-depth discussion of the cooperation details concerning the strategic layout of Israeli market and the brand building. Benny and
September 25 @ 8:00 AM – 9:30 AM You are invited to attend LifeSciences BC’s 2018 Annual General Meeting. The meeting will review the past fiscal year and preview plans for the current fiscal year.
For more information, please visit: www.amazon.com
Shortly after WAT Medical’s leading product to treat nausea-induced vomiting, EmeTerm, received its FDA clearance earlier in April, it has now also received official clearance from Health Canada. Health Canada ensures all of its certified
Vancouver BC – May 14, 2018 – WAT Medical’s leading product to treat nausea-induced vomiting, EmeTerm, has received its FDA clearance earlier in April. Now ready to officially enter the U.S. market as an effective medical
